Home >> Blog >> Inventurus Knowledge Solutions IPO - GMP, Date, Price &Detail
Inventurus Knowledge Solutions IPO - GMP, Date, Price &Detail
Table of Contents
- Inventurus Knowledge Solutions IPO (IKS Health IPO) - Complete Overview
- Inventurus Knowledge Solutions IPO Details
- Company Financial
- The Objective of the Issue
- Peers of Inventurus Knowledge Solutions Limited
- Evaluation
- IPO's Strengths
- IPO’s Weaknesses
- Inventurus Knowledge Solutions IPO GMP
- Promoters and Management of Inventurus Knowledge Solutions Ltd.
- IPO Lead Managers
- Dividend Policy
- Conclusion
Inventurus Knowledge Solutions IPO (IKS Health IPO) - Complete Overview
Inventurus Knowledge Solutions IPO (IKS Health IPO) a Mainboard IPO is a book-built issue of Rs.2,497.92 crore (1.88 Cr Shares) by Inventurus Knowledge Solutions Limited which was founded in March 2008. IKS Health provides services to client dealings, people, companies, etc. with the handling of administrative tasks. Besides doing paperwork and handling admin tasks for these doctors and other healthcare providers, the company also offers clinical support, medical documentation management, virtual medical scribing, etc.
The company is the with healthcare technology that reduces the administrative load for healthcare providers while making it fast and easy for the patient to get access to care. It serves outpatient healthcare enterprises and inpatient care.
Ambulatory services are outpatient services offered whereby medical care is provided to the patient without putting him in the hospital or any facility. The other types of services considered under this are observation, consultation, diagnosis, rehabilitation, intervention, and treatment services.
Inpatient care refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.
As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
Over 13,528 staff include 2,612 clinically trained professionals and a consultative sales force from the US, Canada, and Australia.
This new IPO is to be launched on 12 December 2024, and the initial public offering of this upcoming IPO will end on 16 December 2024.
Detailed Video
Inventurus Knowledge Solutions IPO Details
The Rs.2,497.92 crore Inventurus Knowledge Solutions IPO comprises a wholly fresh issue of 1.88 Cr Shares. The IPO listing date is on December 19, 2024. Inventurus knowledge IPO price is Rs.1265 to Rs.1329.
If you want to apply for the IPO, Click Here to open a Demat Account.
Company Financial
The company’s revenue grew by 75.25% and PAT increased by 21.38% between FYs ended 31 March 2024 and 31 March 2023.
(Amount in Crore)
Period |
30 Sep 2024 |
31 Mar 2024 |
31 Mar 2023 |
Total Assets |
2,790.52 |
3,027.52 |
988.31 |
Total Revenue |
1,294.61 |
1,857.94 |
1,060.16 |
PAT |
208.58 |
370.49 |
305.23 |
Net Worth |
1,377.11 |
1,157.86 |
828.64 |
Total Reserves and Surplus |
1,360.17 |
1,140.94 |
811.80 |
Total Borrowings |
828.63 |
1,193.42 |
- |
Cash Flows
The cash flows for various activities are shown below:
(Amount in millions)
Net Cash Flow In Multiple Activities |
FY2024 |
30 Sep 2023 |
30 Sep 2024 |
Net Cash Flow Operating Activities |
2,097.71 |
1,978.49 |
2,373.56 |
Net Cash Flow Investing Activities |
-11,412.75 |
243.82 |
2,836.90 |
Net Cash Flow Financing Activities |
7,803.68 |
-1,738.86 |
-2,738.10 |
Geography-wise Revenue Bifurcation
The Objective of the Issue
All revenues from the offer will go to the selling shareholders, net of any costs associated with the offer, and the corporation will not receive any of the money.
Peers of Inventurus Knowledge Solutions Limited
No listed companies in India engaged in similar business of comparable size.
Evaluation
The Inventurus Knowledge Solutions IPO price band is between Rs.1265 to Rs.1329 for each Share.
Evaluation of P/E Ratio
Considering the FY ended 31 Mar 2024 with an EPS of Rs.22.37 from the last year, the resulting P/E ratio is 59.41x.
Considering the weighted EPS of Rs.19.69 for the last three years, the P/E ratio is 64.24x.
Comparative Analysis with Listed Peers
No listed peers, hence no comparison is possible.
IPO's Strengths
-
An integrated one-stop service provider with the creepy assortments of outpatient and inpatient care sectors serving the key clientele: patients, physicians, nurses, and health organizations.
-
Creating continued values through outcome delivery by leveraging what technology has to offer in digital evolution transformation and automation.
-
A strong brand in healthcare organizations and physicians.
-
A sustainable yet scalable business model that provides its clients with flexibility and cost savings while having the high-touch 215 engagement through project executive sponsors and access to leadership teams in creating cross selling opportunities.
IPO’s Weaknesses
-
In the past, there have been certain FEMA-related deficiencies in compliance by the company and some of its existing and erstwhile shareholders, concerning the issuance of securities of the Company, delays concerning reporting requirements, and transfer of securities. The company has filed compounding applications with the Reserve Bank of India concerning such contraventions, which are pending with them. Consequently, the company may be subject to regulatory actions and penalties/compounding fees, as the case may take.
-
Had any failure occurred on its part to properly identify, develop, and deploy new solutions that employ artificial intelligence, machine learning, and features into existing solutions like AI-based speech-to-text solutions, then the detrimental impacts could be felt on sales, operational results, etc.
-
As healthcare is regulated, any failure to comply with healthcare laws and regulations may result in the incurring of financial penalties, substantial operational overhaul, or adverse public perception that could put its business in danger.
Inventurus Knowledge Solutions IPO GMP
Inventurus Knowledge Solutions IPO GMP today is Rs.275 as of 09 December 2024. With price of Rs.1329, the estimated Inventurus IPO listing price is Rs.1604 while writing this information.
IKS IPO Timetable (Tentative)
The IKS IPO date is from 12 December to 16 December, with IPO allotment on 17 December, and refund initiation on 18 December. The IPO listing date is on 19 December 2024.
Events |
Date |
IPO Opening Date |
12 December 2024 |
IPO Closing Date |
16 December 2024 |
IPO Allotment Date |
17 December 2024 |
Refund Initiation |
18 December 2024 |
IPO Listing Date |
19 December 2024 |
IKS Health IPO Other Details
IKS Health IPO with a face value of Rs.1 per Share offers a total issue size of 18,795,510 Shares (Rs.2,497.92 Cr) and it will be listed at BSE and NSE.
IPO Opening & Closing date |
12 December 2024 to 16 December 2024 |
Face Value |
Rs.1 per Share |
Issue Price |
Rs.1265 to Rs.1329 |
Lot Size |
11 Shares |
Issue Size |
18,795,510 Shares (Rs.2,497.92 Cr) |
Offer for Sale |
18,795,510 Shares (Rs.2,497.92 Cr) |
Fresh Issue |
- |
Listing At |
BSE, NSE |
Issue Type |
Book Built Issue IPO |
Registrar |
Link Intime India Private Ltd |
Inventurus Knowledge Solutions IPO Lot Size
The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (11 Shares) amounting to Rs.14,619 and 13 Lots (143 Shares) amounting to Rs.1,90,047 respectively, while for HNI investors, the minimum Lot is 14 (154 Shares) amounting to Rs.2,04,666.
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
13 Lots |
S-HNI (Minimum) |
14 Lots |
S-HNI (Maximum) |
68 Lots |
B-HNI (Minimum) |
69 Lots |
IPO Reservation
Institutional Share Portion |
75% |
Retail Investors Share Portion |
10% |
Non-Institutional Shares Portion |
15% |
Promoters and Management of Inventurus Knowledge Solutions Ltd.
-
Sachin Gupta
-
Rekha Jhunjhunwala
-
Aryaman Jhunjhunwala Discretionary Trust
-
Aryavir Jhunjhunwala Discretionary Trust
-
Nishtha Jhunjhunwala Discretionary Trust.
Pre-Issue Promoter Shareholding |
69.73% |
Post-Issue Promoter Shareholding |
60.61% |
IPO Lead Managers
-
ICICI Securities Limited
-
Jefferies India Private Limited
-
JM Financial Limited
-
J.P. Morgan India Private Limited
-
Nomura Financial Advisory And Securities (India) Pvt Ltd.
Dividend Policy
A Dividend of Rs.10 per equity Share was paid out by the company in FY23.
Conclusion
The Inventurus Knowledge IPO (IKS Health IPO) is an opportunity for investors with a specialized focus on healthcare technology and administrative solutions. The IPO has a great financial performance and a sustainable business model assessed between Rs.1265-1329 per share. However, investors should take great care owing to probable regulatory concerns and high P/E valuation. Investors are advised to evaluate the company's growth potential and threats before making any investment decisions.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
DISCLAIMER: This is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
Click Here to stay updated with the Upcoming IPOs.
Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become a beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market!
Open a world of Stock Market by Opening a Demat Account with your favorite Broking firm & Get a trading Strategy worth Rs.15,000!
Click here to open a Free Demat Account.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock.
Frequently Asked Questions
Rs.1265 to Rs.1329
The IPO allotment date is December 17, 2024
December 18, 2024